Surgery Partners, Inc. reported $3.37B of revenue over the trailing twelve months, +4.0% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.37B (to Q2 2026). Net income: −$89M, trailing twelve months to Q2 2026. Free cash flow: $188M, trailing twelve months to Q2 2026. Operating margin: 11%, trailing twelve months to Q2 2026.

SGRYSurgery Partners, Inc.

Healthcare

$13.90-36% 1Y

$13.90

$11.4952 weeks$22.94

SGRY as reported

Surgery Partners, Inc. reported $3.37B of revenue over the trailing twelve months, +4.0% on the year before. 11 reported series are charted on this page, each one as filed.

$3.37B

Revenue, trailing twelve months · to Q2 2026 · +4.0% against the twelve months before

Net income: −$89M
Net income · −51% year on year · trailing twelve months to Q2 2026
Free cash flow: $188M
Free cash flow · +7.0% year on year · trailing twelve months to Q2 2026
Operating margin: 11%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SGRY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.37B	+4.0%	Q2 2026
Net income	−$89M	−51%	Q2 2026
EPS	−$0.69	−52%	Q2 2026
Gross margin	23%	n/a	Q4 2019 · 26 quarters behind
Operating margin	11%	n/a	Q2 2026
Net margin	−2.7%	n/a	Q2 2026
ROE	−6.1%	n/a	Q2 2026
ROA	−1.3%	n/a	Q2 2026
ROIC	6.0%	n/a	Q2 2026
Free cash flow	$188M	+7.0%	Q2 2026
P/E	103	n/a	Q2 2017 · 36 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.